|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.55 TWD | +1.28% |
|
-2.57% | -33.10% |
| 14/03 | Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 06/02 | Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer | CI |
Tanvex BioPharma, Inc. announced the resignation of acting spokesperson and corporate Governance Officer. Name, title, and resume of the previous position holder: Stacey Tsai/Senior Director of Accounting. Name, title, and resume of the new position holder: Pending board appointment.
Effective date: November 30, 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -33.10% | 220M | |
| +5.66% | 111B | |
| +11.23% | 105B | |
| -2.30% | 21.93B | |
| -12.15% | 22.34B | |
| -5.61% | 18.59B | |
| -36.52% | 18.12B | |
| -10.09% | 16.96B | |
| +3.33% | 13.7B | |
| +36.58% | 12.45B |
TANVEX BIOPHARMA, INC. 
